John Sundy serves as Executive at Pandion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John Sundy has executed 2 insider transactions totaling $36.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 115,826 shares valued at $6.9M.
John Sundy currently holds 115,826 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Sundy has been a net buyer of PAND stock. They have purchased $36.0K and sold $0 worth of shares.
John Sundy's most recent insider trade was on Apr 1, 2021, when they sold 115,826 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $18.00 |
| Discretionary |